This is the protocol for a review and there is no abstract. The objectives are as follows:To assess the efficacy and safety of interleukin-1 inhibitors (anakinra, canakinumab, rilonacept) in chronic gout.
CITATION STYLE
Sivera, F., Wechalekar, M. D., Andrés, M., Buchbinder, R., & Carmona, L. (2012). Interleukin-1 inhibitors for chronic gout. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd009994
Mendeley helps you to discover research relevant for your work.